NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
07/25/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
3 | |
07/25/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
3 | |
07/25/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
3 | |
07/25/22 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
3 | |
07/25/22 | 3 | Initial statement of beneficial ownership of securities |
![]() |
3 | |
07/22/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
5 |
07/14/22 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
![]() |
5 | |
06/21/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
3 |
05/10/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
![]() |
![]() ![]() ![]() |
56 |
05/10/22 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
6 |